Trimetazidine dihydrochloride
CAS No. 13171-25-0
Trimetazidine dihydrochloride( Trimetazidine Dihydrochloride )
Catalog No. M11287 CAS No. 13171-25-0
Trimetazidine dihydrochloride is a drug for angina pectoris. Trimetazidine is the first cytoprotective anti-ischemic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 32 | In Stock |
|
| 50MG | 44 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTrimetazidine dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrimetazidine dihydrochloride is a drug for angina pectoris. Trimetazidine is the first cytoprotective anti-ischemic agent.
-
DescriptionTrimetazidine dihydrochloride is a drug for angina pectoris. Trimetazidine is the first cytoprotective anti-ischemic agent , which improves myocardial glucose utilization through inhibition of fatty acid metabolism.(In Vitro):Trimetazidine (1 μM-100 μM; 24 hours; HUVECs) could enhance the viability of the injured HUVECs induces by oxidation in a certain dose-dependent manner.(In Vivo):Trimetazidine (5-20 mg/kg; oral administration; 1 hour; Swiss albino male mice) in 10 mg/kg and 20 mg/kg doses significantly raises the seizure-threshold current in the increasing current electroshock seizure (ICES) test in the mice.
-
In VitroTrimetazidine (1 μM-100 μM; 24 hours; HUVECs) could enhance the viability of the injured HUVECs induces by oxidation in a certain dose-dependent manner. Cell Viability Assay Cell Line:Human umbilical vein endothelial cells (HUVECs)Concentration:1 μM, 10 μM, 100 μM Incubation Time:24 hours Result:Enhanced the viability of the injured HUVECs induced by oxidation.
-
In VivoTrimetazidine (5-20 mg/kg; oral administration; 1 hour; Swiss albino male mice) in 10 mg/kg and 20 mg/kg doses significantly raises the seizure-threshold current in the increasing current electroshock seizure (ICES) test in the mice. Animal Model:Swiss albino male mice (24-35 g)Dosage:5 mg/kg, 10 mg/kg and 20 mg/kg;10 mL/kg body weight Administration:Oral administration; 1 hour Result:In 10 mg/kg and 20 mg/kg doses significantly raised the seizure-threshold current in the ICES test.
-
SynonymsTrimetazidine Dihydrochloride
-
PathwayMetabolic Enzyme/Protease
-
TargetFatty Acid Synthase
-
Recptormitochondrial long-chain 3-ketoacyl thiolase
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number13171-25-0
-
Formula Weight339.26
-
Molecular FormulaC14H22N2O3·2HCl
-
Purity>98% (HPLC)
-
SolubilityWater: 10 mM
-
SMILESCOC1=CC=C(CN2CCNCC2)C(OC)=C1OC.[H]Cl.[H]Cl
-
Chemical Name1-[(2,3,4-Trimethoxyphenyl)methyl]piperazine dihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kantor PF, et al. Circ Res. 2000 Mar 17;86(5):580-8.
molnova catalog
related products
-
trans-C75
trans-C75 is an enantiomer of C75. C75 is an inhibitor of fatty-acid synthase (FASN).
-
Gibberllin A7
Gibberillic acids (GA) are important plant growth hormones that promote plant cell growth and elongation. Gebberillins promote rapid stem and root growth, induce mitotic division and initiate (break dormancy) and increase seed germination rates.
-
FASN-IN-1
FASN-IN-1 is a fatty acid synthase (FASN) inhibitor.
Cart
sales@molnova.com